Results 81 to 90 of about 4,616 (237)
Oral Surgery, Volume 18, Issue 4, Page 472-479, November 2025.ABSTRACT Introduction Systemic immunosuppressive medication and targeted therapies (IMTT) can increase the risk of surgical procedures to patients. The risks of continuing their systemic IMTT medication during the pre‐, peri‐ and post‐operative period must be weighed up against the risk of stopping their medication.
Kirsty Skye Dickson +5 more
wiley +1 more source
Review of: "Diagnostic Accuracy of Bone Scintigraphy in the Early Prediction of MRONJ" [PDF]
, 2021 Leila Ismail
openalex +1 more source
The PI3K/AKT/mTOR Pathway and Oral Diseases: A Bibliometric Analysis From 2008 to 2025
Clinical and Experimental Dental Research, Volume 11, Issue 5, October 2025.ABSTRACT Objectives The phosphoinositide 3 kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway is a key therapeutic target for oral diseases. This study uses bibliometric analysis to identify research trends, knowledge gaps, and the development of PI3K/AKT/mTOR‐targeted therapies.
Yena Gan +7 more
wiley +1 more source
Clinical Oral Implants Research, Volume 36, Issue 10, Page 1173-1201, October 2025.ABSTRACT Objectives Patients receiving antiresorptive medication (AR) for osteoporosis or cancer are at risk of medication‐related osteonecrosis of the jaws (MRONJ), especially after surgical procedures. Dental implant (DI) placement in high‐dose AR (HDAR) patients is widely discouraged, and thorough counseling is recommended for low‐dose AR (LDAR ...
Sanne Werner Moeller Andersen +4 more
wiley +1 more source
Teledentistry as a Supportive Tool for Dentists in Diagnosing MRONJ in Northern Cyprus [PDF]
, 2021 Mujgan Firincioglulari, Kaan Orhan
openalex +1 more source
Journal of Translational Medicine, 2017 Background The medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy [MRONJ (BP)] is characterized by non-healing exposed bone in the maxillofacial region. The pathogenesis of MRONJ (BP) is not fully understood.
Christian Gross +6 more
doaj +1 more source
The preventive effect of photocrosslinked Hep/GelMA hydrogel loaded with PRF on MRONJ
BMC Oral HealthMedication-related osteonecrosis of the Jaw (MRONJ) is a rare but severe side effect in patients treated with medications such as Bisphosphonates (BPs). Its pathophysiological mechanism needs to be more precise.
Lu Tao +9 more
semanticscholar +1 more source
Effect of pentoxifylline and tocopherol for MRONJ patients: A systematic review [PDF]
, 2022 Moo-Kyeong Kim +4 more
openalex +1 more source
Dental journalMedication-related osteonecrosis of the jaw (MRONJ) is a drug complication that can occur in patients taking antiresorptive or antiangiogenic drugs. Although it is a well-documented disease, there is no widely accepted treatment.
P. Vescovi +4 more
semanticscholar +1 more source
B.P.F.C Pure Growth Factor, PDT and LLLT for the Treatment of Severe MRONJ Non-responsive to Prolonged Antibiotic Therapy [PDF]
, 2021 Raffaello Viganò +4 more
openalex +1 more source